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Introduction
Androgenetic alopecia (AGA), or male baldness pat-
tern androgenetic alopecia, is the most common form of 
hair loss in humans and affects 80% of Caucasian men 
and 40–50% of Caucasian women [1]. In AGA, there is an 
alteration of the hair growth cycle [2]. AGA is character-
ized by miniaturization of the hair follicle, a phenomenon 
that occurs due to a rapid change from the anagen phase 
to the catagen/telogen phase, which probably reflects an 
ongoing follicle apoptotic process [3]. During the hair 
growth cycle, there is an important interaction between 
growth factors such as cytokines, hormones, and neu-
rotransmitters and their receptors [4]. However, it is still 
not clear if AGA results from disruption of proliferation 
or an increase in apoptosis in the hair follicle [5]. Despite 
this, one of the main targets of topic and systemic anti-
oxidant therapies for AGA is apoptosis inhibition [6]. In 
fact, studies of drugs such as finasteride have shown de-
creased levels of caspases after 6 months of treatment in 
patients with AGA compared with healthy subjects [7]. 
Most studies evaluating caspases in patients with AGA 
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Abstract
Androgenetic alopecia (AGA) or male pattern baldness is the 
most common form of hair loss in humans. Despite being a 
very frequent dermatological entity, molecular pathophysi-
ology remains unclear. Several authors relate the presenta-
tion of AGA with a premature apoptotic process during the 
anagen phase and with an inflammatory microenvironment 
in the hair follicle. We evaluated a panel of 30 genes associ-
ated with inflammation and apoptosis in 5 AGA patients by 
targeted RNA-Seq. WNT7A gene was highly expressed in pa-
tients in stages 3V to 5 on the Hamilton-Norwood scale com-
pared to patients with 5A stage. CASP7 and TNF genes were 
overexpressed in stages 3V and 4 compared to stages 5 and 
5A. Overexpression of these genes detected only at early 
stages of AGA proves the role of WNT pathway, apoptosis, 
and inflammation in the development of this disorder.
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have been performed with immune-based techniques, 
such as immunohistochemistry and ELISA, to analyze 
gene expression. The purpose of this article was to evalu-
ate the expression of a panel of genes associated with in-
flammation and apoptosis in AGA using targeted RNA-
Seq.
Material and Methods
Tissue Samples and RNA Isolation
Ten patients with AGA (3V to 5A) and 2 control subjects were 
included in the study (Table 1). Clinical and dermatological eval-
uation was performed to confirm the diagnosis of AGA. Patients 
with diagnosis of seborrheic dermatitis, telogen effluvium, and 
other types of alopecias were excluded from this study. The Ethics 
and Research Committees of the School of Medicine and Univer-
sity Hospital of Universidad Autonoma de Nuevo Leon at Mon-
terrey, Mexico, approved and registered the study protocol with 
the code BI14-001 to be conducted from January 2014 to August 
2016. Two scalp biopsies of 4 mm were collected from each sub-
ject. Patients with AGA consisted of males aged from 18 to 40 
years old, who had not been treated with finasteride or minoxidil. 
Biopsies were obtained from the affected area and the occipital 
region in these patients. Biopsies from control subjects were col-
lected from the vertex and occipital regions. RNAlater® solution 
(Thermo-Fisher Scientific, Waltham, MA, USA) for RNA stabili-
zation and storage was used to preserve biopsies. RNA from scalp 
biopsies was isolated with the RNeasy Blood and Tissue kitTM 
(QIAGEN, Hilden, Germany) and was quantified with the Quant-
iTTM RiboGreen® RNA Assay kit (Thermo-Fisher Scientific). 
Samples collected for this study were carefully preserved and 
stored at –80 ° C until use to maintain RNA integrity before the 
molecular analyses were performed. The RQI (RNA quality indi-
cator) number was evaluated using the ExperionTM automated 
electrophoresis system (Bio-Rad, Hercules, CA, USA). The cutoff 
for the analyzed RNA samples had values above 7.8. Values from 
7 to 10 are considered of good quality for microarray analysis or 
sequencing [8]. 
Next-Generation Sequencing
RNA (100 ng) from 5 patients (biopsies from affected and oc-
cipital areas) and 2 control subjects was used to obtain cDNA using 
the ProtoScript Reverse Transcriptase kit (New England Biolabs, 
Ipswich, MA, USA) and for the library preparation using TruSeq® 
Targeted RNA (Illumina, San Diego, CA, USA). Sequencing of 30 
selected transcripts plus an endogenous GAPDH transcript con-
trol (Table 2) was carried out with MiSeq® Reagent Kit v3 (Illu-
mina) (150 cycles) and Truseq® Target RNA Custom Panel Librar-
ies (Illumina). Libraries were quantified using Quant-iTTM Pico-
Green® dsDNA Assay Kit (Thermo-Fisher Scientific). Targeted 
RNA-Seq data analysis was performed using TruSeq Targeted 
RNA v1.0 App in BaseSpace (Illumina). After demultiplexing and 
FASTQ file generation, readings of each sample were aligned 
against specified references in the manifest using a banded Smith-
Waterman alignment, which produces target hits files that contain 
raw aligned replicate counts for each transcript. Differential ex-
pression analysis was performed in which depth of sequencing 
normalization, variance estimation, and p values were calculated. 
p values reaching statistical significance for the differential expres-
sion were adjusted for false discovery rate (FDR) using the Ben-
jamini-Hochberg method. A heat map was generated using Graph 
Pad Prism 7 (Graph Pad Software, Inc., La Jolla, CA, USA), con-
sidering the gene expression value as log10 of the number of read-
ings for each gene per patient.
Validation by Real-Time PCR
Differential expression of CASP7, WNT7A, and TNF genes 
identified by targeted RNA-Seq was confirmed using real-time 
PCR analysis. The altered expression of WNT7A (ID: Hs01114990_
m1), CASP7 (ID: Hs00169152_m1), and TNF (ID: Hs00174128_
m1) genes in AGA were further confirmed in independent scalp 
biopsies, using AK3 (ID: Hs00750254_s1) as endogenous gene, 
based on the low variability observed in all samples tested by a pre-
vious microarray analysis. First strand cDNA was then synthesized 
from 2 µg total RNA using Superscript First Strand cDNA Synthe-
sis Kit (Invitrogen, Carlsbad, CA, USA). Subsequently, real-time 
PCR reactions were performed using cDNA, TaqMan Universal 
PCR Master Mix, and Taqman Gene Expression Assays (Thermo-
Fisher). The analysis was performed in a LightCycler 480 II Real-
Time PCR System (Roche Applied Science, Pleasanton, CA, USA), 
all according to the manufacturers’ instructions.
Statistical Analysis
Comparison of numerical variables between the study groups 
was made using Student t test for independent samples normally 
distributed. p values <0.05 were considered significant. An un-
paired Student t test analysis was used to detect gene expression by 
real-time PCR analyses using GraphPad Prism 7 software.
Results
Next-Generation Sequencing
A panel of 30 genes associated with inflammation and 
apoptosis was performed for 5 patients with AGA and 2 
controls by targeted RNA-Seq panel (Table 2). Higher ex-
pression of CASP3 (p = 0.0003), CASP7 (p = 0.0001), 
Table 1. Clinical data of the studied groups
Variables Patients Controls
Age range, years 22 – 52 (33.68 ± 10.6) 21 – 22 (21.5 ± 0.7)
Males, n (%) 10 (100) 2 (100)







Range of duration of
disease, months 24 – 360 (108 ± 93.6) 0
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Table 2. Genes included in the RNA-Seq panel
Gene Function
TNF This cytokine is involved in the regulation of a wide spectrum of biological processes including 
cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation
CASP3 Is a member of the cysteine-aspartic acid protease (caspase) family; plays a central role in the 
execution phase of cell apoptosis
CASP7 Is a member of the cysteine-aspartic acid protease (caspase) family; plays a central role in the 
execution phase of cell apoptosis/inflammation
CASP8 Is a member of the cysteine-aspartic acid protease (caspase) family; plays a central role in the 
execution phase of cell apoptosis
CASP10 Is a member of the cysteine-aspartic acid protease (caspase) family; plays a central role in the 
execution phase of cell apoptosis
BAX BCL2-associated X protein, act as anti- or pro-apoptotic regulator that is involved in a wide 
variety of cellular activities
TNFRSF1A Is one of the major receptors for the tumor necrosis factor-α; can activate NF-κB, mediate 
apoptosis, and function as a regulator of inflammation
TXN Thioredoxin; inhibits oxidative stress and caspase 3 activity
BCL2 Encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death
POMC One peptide produced from the POMC protein is α-MSH involved in regulating the pigment-
producing cells of the skin and hair (melanocytes), where it binds to melanocortin 1 receptor 
(MC1R)/inflammation
MC1R Controls melanogenesis/inflammation inhibitor
MC4R Encoded protein interacts with adrenocorticotropic and MSH hormones and is mediated by G 
proteins/inflammation inhibitor
TPT1 Microtubule stabilization/inflammation
FASLG Fas ligand (TNF superfamily, member 6); induction of apoptosis triggered by binding to FAS
BCL3 Involved in regulation of cell proliferation and contributes to transcriptional regulation of 
NFKB. Pro-survival and pro-inflammatory
NFKB1 Inflammation/cell damage. Nuclear Factor Kappa B Subunit 1; is a transcription regulator 
which stimulates the expression of genes involved in a wide variety of biological function
TYRP1 Encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important 
role in the melanin biosynthetic pathway. Inflammation
DCT Regulating eumelanin and phaeomelanin levels/inflammation
MLANA Involved in melanosome biogenesis/oxidative stress
WNT7A Wnt Family Member 7A, implicated in oncogenesis and in several developmental processes. 
Hair growth/inflammation inhibitor
MITF Involved in melanocyte survival, controls the expression of genes related to melanin synthesis. 
Cell differentiation, proliferation, and survival/inflammation
MAPK1 Mitogen-activated protein kinase 1, involved in cell proliferation and differentiation/
inflammation
CAPN3 Intracellular protease/activated in apoptotic cells
CFLAR Is a regulator of apoptosis and is structurally similar to caspase-8/apoptosis inhibitor
CCBL2 Cysteine conjugate-beta lyase 2, involved in the regulation of oxidative stress/inflammation
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BCL3 (p = 0.0166), WNT7A (p = 0.0005), and TNF (p = 
0.0004) was found in the affected area of patients with 3V, 
4, and 5; and underexpressed in 5A patients (Fig. 1).
Validation by Real-Time PCR
Targeted RNA-Seq analysis was confirmed using real-
time PCR analyses for selected genes. Overexpression of 
CASP7 (p = 0.0001) and TNF (p = 0.0005) in patients with 
types 3V and 4 was confirmed. Underexpression of these 
same genes was also confirmed in patients with types 5 
and 5A. WNT7A (p = 0.0001) was overexpressed in pa-
tients with types 3V to 5, whereas it was underexpressed 
in type 5A patients. Differences were confirmed using un-
paired Student t test between two groups (3V–4 vs. 5–5A 
and 3V–5 vs. 5A) (Fig. 2). Expression analyses of CASP3 
and BCL3 were not evaluated due to limitations in sample 
availability.
Discussion
The role of the Wnt pathway in AGA is well estab-
lished, as it is involved in the hair growth cycle and the 
morphogenesis of the hair follicle. Therefore, overexpres-
sion of WNT7A in moderate degrees (3V to 5) and its 
underexpression in the 5A severe phenotype prove that 
in late stages of AGA, the hair growth cycle is suppressed, 
causing follicles to remain in the catagen/telogen phase. 
In this study, CASP7 and TNF showed overexpression in 
stages 3V and 4, but not in stages 5 and 5A (Fig. 1). CASP7 
belongs to the subgroup of executioner caspases, as does 
Gene Function
CDC5L Cell cycle control/inflammation
CSNK1G3 WNT signaling/inflammation
PHACTR2 Phosphatase and actin regulator 2/inflammatory cytokine in dermal cells
GGT1 Involved in maintenance of intracellular GSH level. It is part of the cellular antioxidant defense 
mechanism/inflammation
GAPDH Glyceraldehyde-3-phosphate dehydrogenase. Endogenous control/constitutive expression.
GPD1 Glycerol-3-phosphate dehydrogenase 1, involved in the redox metabolism
GAPDH Glyceraldehyde-3-phosphate dehydrogenase. Endogenous control/constitutive expression
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Fig. 1. Heat map of the profile of expression differences between 
the balding regions of patients with types 3V to 5A of androge-
netic alopecia (Hamilton-Norwood scale). Genes with high ex-
pression are observed in red (upregulated), while those with low 
expression are represented in green (downregulated) (p < 0.05). 
Data was processed using the Graph Pad Prism 7 program. Each 
column represents a type of androgenetic alopecia according to the 
Hamilton-Norwood scale and each row represents a gene. The 
gene expression value corresponds to log10 of the number of read-
ings for each gene per patient.
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CASP3 and CASP6. Interestingly, CASP7 proteolytic 
maturation is involved in apoptosis and inflammation, in 
contrast to CASP3, which participates in the apoptosis 
process only [9]. CASP7 expression is observed in cul-
tured keratinocytes and in the anagen phase of the hair 
follicle in vivo [10, 11]. Nevertheless, the role of CASP7 in 
the hair follicle is still controversial, since the gene re-
mains active during the proliferation and differentiation 
processes in absence of evident apoptosis, suggesting ad-
ditional roles for this enzyme [12]. 
Conversely, TNF is an inflammatory cytokine that 
plays a well-established role and acts on several different 
signaling pathways through two cell surface receptors, 
being probably the most potent inducer of apoptosis [13]. 
TNF has been recently added to the list of growth factors 
regulating hair follicle morphogenesis and has been tra-
ditionally associated with host defense, immunity, in-
flammation, and cancer [14]. TNF appears to protect 
against hair loss. The blockade of TNF by monoclonal 
antibodies resulted in alopecia areata in a patient treated 
with infliximab [15]. TNF overexpression in early phases 
of AGA and its downregulation in advanced stages of the 
disease suggest a protective effect for this protein.
Caspase-3 plays an important role in apoptosis, as it is 
activated in the apoptotic cell by extrinsic (death ligand) 
and intrinsic (mitochondrial) pathways [16]. Overex-
pression of CASP3 was only found in stages 3V to 5, indi-
cating that this gene is involved in early stages of AGA. In 
contrast, CASP3 is less expressed in advanced stages, 
probably reflecting the profuse destruction of hair folli-
cles and the resulting perifollicular fibrosis. These results 
coincide with the report by Fawzi et al. [17], which stated 
that DKK1 levels, a WNT inhibitor, only influenced early 
stages of AGA. Overexpression of BCL3 in the clinical 
presentations 3V to 5 of AGA may reflect a response of 
the affected hair follicles to CASP3 expression, since ele-
vated BCL3 activity points towards increased cell prolif-
eration and survival [18].
There are several limitations in our study. The sam-
ple size for each type of the Hamilton-Norwood scale 
needs to be increased to clarify CASP3 and WNT7A 
overexpression at early stages, like in types 1–3, where 
minimal bitemporal hair recession is evident. In addi-
tion, the number of transcripts analyzed in this study 
may result limited to study additional pathways in-
volved in AGA progression. Due to the small number 
of samples, it was not possible to evaluate the expres-
sion of CASP3 and BCL3 genes by real-time PCR, which 
were also overexpressed in types 3V to 5 AGA patients. 
However, in this pilot study we proved the efficiency of 
molecular techniques as RNA-Seq and real-time PCR 
for the analysis of androgenetic alopecia, since to date, 
most studies evaluating caspases in patients with AGA 
have used immunohistochemistry and ELISA tech-
niques to analyze the gene expression. It is also impor-
tant to mention that the number of samples has been 
the limitation of other breakthrough studies in the AGA 
research field, since the diagnosis of this entity does not 
required a biopsy. Also, techniques such as microarray, 
sequencing, and real-time PCR generate a higher cost, 











































Fig. 2. Validation of the expression of WNT7, CASP7, and TNF genes by real-time PCR. Unpaired t test was used 
to detect differences in gene expression between 2 groups (3V–4 and 5–5A types) using the Graph Pad Prism 7 
software. Significance: *** p < 0.001 and **** p < 0.0001.
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In conclusion, this study proves that WNT7A, CASP7, 
and TNF are overexpressed in alopecia areas in patients 
with AGA at early stages of the disease. This result con-
firms the role of WNT pathway, apoptosis, and inflam-
mation on early stages of this disorder. Targeted RNA-
Seq is a useful technique for the evaluation of gene expres-
sion in AGA samples, as it only requires a small amount 
of input material for evaluating large numbers of genes.
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